BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 16398083)

  • 1. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ongoing NovoSeven trials.
    Erhardtsen E
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To general haemostasis--the evidence-based route.
    Erhardtsen E
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII: mechanisms of action and current indications.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2010 Jul; 36(5):485-92. PubMed ID: 20632246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Off-license" use of recombinant activated factor VII.
    Ghorashian S; Hunt BJ
    Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa: a review on its clinical use.
    Franchini M
    Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
    Hartmann M; Sucker C
    Neurocrit Care; 2007; 6(2):149-57. PubMed ID: 17522800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative use of recombinant activated factor VII (rFVIIa).
    De Gasperi A
    Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII in patients at high risk of bleeding.
    Kubisz P; Stasko J
    Hematology; 2004; 9(5-6):317-32. PubMed ID: 15763970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII: 30 years of research and innovation.
    Hedner U
    Blood Rev; 2015 Jun; 29 Suppl 1():S4-8. PubMed ID: 26073368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of recombinant-activated factor VII in neurocritical care.
    Fewel ME; Park P
    Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.
    Di Minno MND; Ambrosino P; Myasoedova V; Amato M; Ventre I; Tremoli E; Minno AD
    Curr Pharm Des; 2017; 23(7):1125-1131. PubMed ID: 28034354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.